|
|
|
|
|
|
|
||
Address correspondence to Wen-Hui Wang, Dept. of Pharmacology, New York Medical College, Valhalla, NY 10595. Fax: (914) 347-4956; email: wenhui_wang{at}nymc.edu
We used the patch-clamp technique to study the effect of arachidonic acid (AA) on epithelial Na channels (ENaC) in the rat cortical collecting duct (CCD). Application of 10 µM AA decreased the ENaC activity defined by NPo from 1.0 to 0.1. The dose–response curve of the AA effect on ENaC shows that 2 µM AA inhibited the ENaC activity by 50%. The effect of AA on ENaC is specific because neither 5,8,11,14-eicosatetraynoic acid (ETYA), a nonmetabolized analogue of AA, nor 11,14,17-eicosatrienoic acid mimicked the inhibitory effect of AA on ENaC. Moreover, inhibition of either cyclooxygenase (COX) with indomethacin or cytochrome P450 (CYP)
-hydroxylation with N-methylsulfonyl-12,12-dibromododec-11-enamide (DDMS) failed to abolish the effect of AA on ENaC. In contrast, the inhibitory effect of AA on ENaC was absent in the presence of N-methylsulfonyl-6-(propargyloxyphenyl)hexanamide (MS-PPOH), an agent that inhibits CYP-epoxygenase activity. The notion that the inhibitory effect of AA is mediated by CYP-epoxygenase–dependent metabolites is also supported by the observation that application of 200 nM 11,12-epoxyeicosatrienoic acid (EET) inhibited ENaC in the CCD. In contrast, addition of 5,6-, 8,9-, or 14,15-EET failed to decrease ENaC activity. Also, application of 11,12-EET can still reduce ENaC activity in the presence of MS-PPOH, suggesting that 11,12-EET is a mediator for the AA-induced inhibition of ENaC. Furthermore, gas chromatography mass spectrometry analysis detected the presence of 11,12-EET in the CCD and CYP2C23 is expressed in the principal cells of the CCD. We conclude that AA inhibits ENaC activity in the CCD and that the effect of AA is mediated by a CYP-epoxygenase–dependent metabolite, 11,12-EET.
Key Words: Na reabsorption • ENaC • epoxyeicosatrienoic acid • cortical collecting duct • MS-PPOH
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Sun, W. Liu, D.-H. Lin, P. Yue, R. Kemp, L. M. Satlin, and W.-H. Wang Epoxyeicosatrienoic Acid Activates BK Channels in the Cortical Collecting Duct J. Am. Soc. Nephrol., March 1, 2009; 20(3): 513 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ren, M. A. D'Ambrosio, J. L. Garvin, H. Wang, and O. A. Carretero Possible Mediators of Connecting Tubule Glomerular Feedback Hypertension, February 1, 2009; 53(2): 319 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Athirakul, J. A. Bradbury, J. P. Graves, L. M. DeGraff, J. Ma, Y. Zhao, J. F. Couse, R. Quigley, D. R. Harder, X. Zhao, et al. Increased blood pressure in mice lacking cytochrome P450 2J5 FASEB J, December 1, 2008; 22(12): 4096 - 4108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Liclican, J. C. McGiff, J. R. Falck, and M. A. Carroll Failure to upregulate the adenosine2A receptor-epoxyeicosatrienoic acid pathway contributes to the development of hypertension in Dahl salt-sensitive rats Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1696 - F1704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Wang, Y. Wei, J. R. Falck, K. R. Atcha, and W.-H. Wang Arachidonic acid inhibits basolateral K channels in the cortical collecting duct via cytochrome P-450 epoxygenase-dependent metabolic pathways Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1441 - F1447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Minuz, H. Jiang, C. Fava, L. Turolo, S. Tacconelli, M. Ricci, P. Patrignani, A. Morganti, A. Lechi, and J. C. McGiff Altered Release of Cytochrome P450 Metabolites of Arachidonic Acid in Renovascular Disease Hypertension, May 1, 2008; 51(5): 1379 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Dreisbach, J. C. Rice, S. Japa, J. W. Newman, A. Sigel, R. S. Gill, A. E. Hess, A. C. Cemo, J. P. Fonseca, B. D. Hammock, et al. Salt Loading Increases Urinary Excretion of Linoleic Acid Diols and Triols in Healthy Human Subjects Hypertension, March 1, 2008; 51(3): 755 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Jin, Z. Wang, Y. Zhang, B. Yang, and W.-H. Wang PGE2 inhibits apical K channels in the CCD through activation of the MAPK pathway Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1299 - F1307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-G. Zhao, M. Zhang, X.-M. Zeng, X.-W. Fei, L.-Y. Liu, Z.-H. Zhang, and Y.-A. Mei Flufenamic Acid Bi-Directionally Modulates the Transient Outward K+ Current in Rat Cerebellar Granule Cells J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 195 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Huang, C. Morisseau, J. Wang, T. Yang, J. R. Falck, B. D. Hammock, and M.-H. Wang Increasing or stabilizing renal epoxyeicosatrienoic acid production attenuates abnormal renal function and hypertension in obese rats Am J Physiol Renal Physiol, July 1, 2007; 293(1): F342 - F349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pierre, M.-O. Husson, R. L. Berre, J.-L. Desseyn, C. Galabert, L. Beghin, C. Beermann, A. Dagenais, Y. Berthiaume, B. Cardinaud, et al. Omega-3 polyunsaturated fatty acids improve host response in chronic Pseudomonas aeruginosa lung infection in mice Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1422 - L1431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Huang, H.-H. Chang, Y. Xu, D. S. Reddy, J. Du, Y. Zhou, Z. Dong, J. R. Falck, and M.-H. Wang Epoxyeicosatrienoic Acid Inhibition Alters Renal Hemodynamics During Pregnancy Exp Biol Med, December 1, 2006; 231(11): 1744 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sun, D.-H. Lin, T. Wang, E. Babilonia, Z. Wang, Y. Jin, R. Kemp, A. Nasjletti, and W.-H. Wang Low Na intake suppresses expression of CYP2C23 and arachidonic acid-induced inhibition of ENaC Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1192 - F1200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Sacerdoti, M. Bolognesi, M. Di Pascoli, A. Gatta, J. C. McGiff, M. L. Schwartzman, and N. G. Abraham Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1999 - H2002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.H. Messerli, G. Mancia, C.R. Conti, A.C. Hewkin, S. Kupfer, A. Champion, R. Kolloch, A. Benetos, C.J. Pepine, K. Nakagawa, et al. Lowering of Blood Pressure--The Lower, the Better?: Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous? Ann Intern Med 144: 884-893, 2006 J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2345 - 2352. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Lu, D. Ye, X. Wang, J. M. Seubert, J. P. Graves, J. A. Bradbury, D. C. Zeldin, and H.-C. Lee Cardiac and vascular KATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms J. Physiol., September 1, 2006; 575(2): 627 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wei, P. Sun, Z. Wang, B. Yang, M. A. Carroll, and W.-H. Wang Adenosine inhibits ENaC via cytochrome P-450 epoxygenase-dependent metabolites of arachidonic acid Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1163 - F1168. [Abstract] [Full Text] [PDF]
|
|
|
|
